The global market for Pet Biopharmaceuticals was estimated to be worth US$ 14270 million in 2023 and is forecast to a readjusted size of US$ 19590 million by 2030 with a CAGR of 4.7% during the forecast period 2024-2030

Pet Biopharmaceuticals - Market

Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 47%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pet Biopharmaceuticals, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Pet Biopharmaceuticals by region & country, by Type, and by Application.

The Pet Biopharmaceuticals market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Biopharmaceuticals.

Market Segmentation

Scope of Pet Biopharmaceuticals - Market Report

Report Metric	Details
Report Name	Pet Biopharmaceuticals - Market
Forecasted market size in 2030	US$ 19590 million
CAGR	4.7%
Forecasted years	2024 - 2030
Segment by Type:	Antiparasitic Biological Products Antibacterial Others
Segment by Application	Prevention Treatment
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Zoetis, Boehringer Ingelheim, Merck, Elanco, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Ouro Fino Saude, Norbrook, Jindun, Chopperlvya Animal Health, CAHIC
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Pet Biopharmaceuticals manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Pet Biopharmaceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Pet Biopharmaceuticals in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Pet Biopharmaceuticals - Market size in 2030?

Ans: The Pet Biopharmaceuticals - Market size in 2030 will be US$ 19590 million.

What is the Pet Biopharmaceuticals - Market share by region?

Ans: In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry.

Who are the main players in the Pet Biopharmaceuticals - Market report?

Ans: The main players in the Pet Biopharmaceuticals - Market are Zoetis, Boehringer Ingelheim, Merck, Elanco, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Ouro Fino Saude, Norbrook, Jindun, Chopperlvya Animal Health, CAHIC

What are the Application segmentation covered in the Pet Biopharmaceuticals - Market report?

Ans: The Applications covered in the Pet Biopharmaceuticals - Market report are Prevention, Treatment

What are the Type segmentation covered in the Pet Biopharmaceuticals - Market report?

Ans: The Types covered in the Pet Biopharmaceuticals - Market report are Antiparasitic, Biological Products, Antibacterial, Others

1 Market Overview

1.1 Pet Biopharmaceuticals Product Introduction

1.2 Global Pet Biopharmaceuticals Market Size Forecast

1.3 Pet Biopharmaceuticals Market Trends & Drivers

1.3.1 Pet Biopharmaceuticals Industry Trends

1.3.2 Pet Biopharmaceuticals Market Drivers & Opportunity

1.3.3 Pet Biopharmaceuticals Market Challenges

1.3.4 Pet Biopharmaceuticals Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Pet Biopharmaceuticals Players Revenue Ranking (2023)

2.2 Global Pet Biopharmaceuticals Revenue by Company (2019-2024)

2.3 Key Companies Pet Biopharmaceuticals Manufacturing Base Distribution and Headquarters

2.4 Key Companies Pet Biopharmaceuticals Product Offered

2.5 Key Companies Time to Begin Mass Production of Pet Biopharmaceuticals

2.6 Pet Biopharmaceuticals Market Competitive Analysis

2.6.1 Pet Biopharmaceuticals Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Pet Biopharmaceuticals Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Biopharmaceuticals as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Antiparasitic

3.1.2 Biological Products

3.1.3 Antibacterial

3.1.4 Others

3.2 Global Pet Biopharmaceuticals Sales Value by Type

3.2.1 Global Pet Biopharmaceuticals Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Pet Biopharmaceuticals Sales Value, by Type (2019-2030)

3.2.3 Global Pet Biopharmaceuticals Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Prevention

4.1.2 Treatment

4.2 Global Pet Biopharmaceuticals Sales Value by Application

4.2.1 Global Pet Biopharmaceuticals Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Pet Biopharmaceuticals Sales Value, by Application (2019-2030)

4.2.3 Global Pet Biopharmaceuticals Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Pet Biopharmaceuticals Sales Value by Region

5.1.1 Global Pet Biopharmaceuticals Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Pet Biopharmaceuticals Sales Value by Region (2019-2024)

5.1.3 Global Pet Biopharmaceuticals Sales Value by Region (2025-2030)

5.1.4 Global Pet Biopharmaceuticals Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Pet Biopharmaceuticals Sales Value, 2019-2030

5.2.2 North America Pet Biopharmaceuticals Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Pet Biopharmaceuticals Sales Value, 2019-2030

5.3.2 Europe Pet Biopharmaceuticals Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Pet Biopharmaceuticals Sales Value, 2019-2030

5.4.2 Asia Pacific Pet Biopharmaceuticals Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Pet Biopharmaceuticals Sales Value, 2019-2030

5.5.2 South America Pet Biopharmaceuticals Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Pet Biopharmaceuticals Sales Value, 2019-2030

5.6.2 Middle East & Africa Pet Biopharmaceuticals Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Pet Biopharmaceuticals Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Pet Biopharmaceuticals Sales Value

6.3 United States

6.3.1 United States Pet Biopharmaceuticals Sales Value, 2019-2030

6.3.2 United States Pet Biopharmaceuticals Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Pet Biopharmaceuticals Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Pet Biopharmaceuticals Sales Value, 2019-2030

6.4.2 Europe Pet Biopharmaceuticals Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Pet Biopharmaceuticals Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Pet Biopharmaceuticals Sales Value, 2019-2030

6.5.2 China Pet Biopharmaceuticals Sales Value by Type (%), 2023 VS 2030

6.5.3 China Pet Biopharmaceuticals Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Pet Biopharmaceuticals Sales Value, 2019-2030

6.6.2 Japan Pet Biopharmaceuticals Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Pet Biopharmaceuticals Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Pet Biopharmaceuticals Sales Value, 2019-2030

6.7.2 South Korea Pet Biopharmaceuticals Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Pet Biopharmaceuticals Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Pet Biopharmaceuticals Sales Value, 2019-2030

6.8.2 Southeast Asia Pet Biopharmaceuticals Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Pet Biopharmaceuticals Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Pet Biopharmaceuticals Sales Value, 2019-2030

6.9.2 India Pet Biopharmaceuticals Sales Value by Type (%), 2023 VS 2030

6.9.3 India Pet Biopharmaceuticals Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Zoetis

7.1.1 Zoetis Profile

7.1.2 Zoetis Main Business

7.1.3 Zoetis Pet Biopharmaceuticals Products, Services and Solutions

7.1.4 Zoetis Pet Biopharmaceuticals Revenue (US$ Million) & (2019-2024)

7.1.5 Zoetis Recent Developments

7.2 Boehringer Ingelheim

7.2.1 Boehringer Ingelheim Profile

7.2.2 Boehringer Ingelheim Main Business

7.2.3 Boehringer Ingelheim Pet Biopharmaceuticals Products, Services and Solutions

7.2.4 Boehringer Ingelheim Pet Biopharmaceuticals Revenue (US$ Million) & (2019-2024)

7.2.5 Boehringer Ingelheim Recent Developments

7.3 Merck

7.3.1 Merck Profile

7.3.2 Merck Main Business

7.3.3 Merck Pet Biopharmaceuticals Products, Services and Solutions

7.3.4 Merck Pet Biopharmaceuticals Revenue (US$ Million) & (2019-2024)

7.3.5 Elanco Recent Developments

7.4 Elanco

7.4.1 Elanco Profile

7.4.2 Elanco Main Business

7.4.3 Elanco Pet Biopharmaceuticals Products, Services and Solutions

7.4.4 Elanco Pet Biopharmaceuticals Revenue (US$ Million) & (2019-2024)

7.4.5 Elanco Recent Developments

7.5 Virbac

7.5.1 Virbac Profile

7.5.2 Virbac Main Business

7.5.3 Virbac Pet Biopharmaceuticals Products, Services and Solutions

7.5.4 Virbac Pet Biopharmaceuticals Revenue (US$ Million) & (2019-2024)

7.5.5 Virbac Recent Developments

7.6 Dechra Veterinary Products

7.6.1 Dechra Veterinary Products Profile

7.6.2 Dechra Veterinary Products Main Business

7.6.3 Dechra Veterinary Products Pet Biopharmaceuticals Products, Services and Solutions

7.6.4 Dechra Veterinary Products Pet Biopharmaceuticals Revenue (US$ Million) & (2019-2024)

7.6.5 Dechra Veterinary Products Recent Developments

7.7 Ceva

7.7.1 Ceva Profile

7.7.2 Ceva Main Business

7.7.3 Ceva Pet Biopharmaceuticals Products, Services and Solutions

7.7.4 Ceva Pet Biopharmaceuticals Revenue (US$ Million) & (2019-2024)

7.7.5 Ceva Recent Developments

7.8 Vetoquinol

7.8.1 Vetoquinol Profile

7.8.2 Vetoquinol Main Business

7.8.3 Vetoquinol Pet Biopharmaceuticals Products, Services and Solutions

7.8.4 Vetoquinol Pet Biopharmaceuticals Revenue (US$ Million) & (2019-2024)

7.8.5 Vetoquinol Recent Developments

7.9 Ouro Fino Saude

7.9.1 Ouro Fino Saude Profile

7.9.2 Ouro Fino Saude Main Business

7.9.3 Ouro Fino Saude Pet Biopharmaceuticals Products, Services and Solutions

7.9.4 Ouro Fino Saude Pet Biopharmaceuticals Revenue (US$ Million) & (2019-2024)

7.9.5 Ouro Fino Saude Recent Developments

7.10 Norbrook

7.10.1 Norbrook Profile

7.10.2 Norbrook Main Business

7.10.3 Norbrook Pet Biopharmaceuticals Products, Services and Solutions

7.10.4 Norbrook Pet Biopharmaceuticals Revenue (US$ Million) & (2019-2024)

7.10.5 Norbrook Recent Developments

7.11 Jindun

7.11.1 Jindun Profile

7.11.2 Jindun Main Business

7.11.3 Jindun Pet Biopharmaceuticals Products, Services and Solutions

7.11.4 Jindun Pet Biopharmaceuticals Revenue (US$ Million) & (2019-2024)

7.11.5 Jindun Recent Developments

7.12 Chopperlvya Animal Health

7.12.1 Chopperlvya Animal Health Profile

7.12.2 Chopperlvya Animal Health Main Business

7.12.3 Chopperlvya Animal Health Pet Biopharmaceuticals Products, Services and Solutions

7.12.4 Chopperlvya Animal Health Pet Biopharmaceuticals Revenue (US$ Million) & (2019-2024)

7.12.5 Chopperlvya Animal Health Recent Developments

7.13 CAHIC

7.13.1 CAHIC Profile

7.13.2 CAHIC Main Business

7.13.3 CAHIC Pet Biopharmaceuticals Products, Services and Solutions

7.13.4 CAHIC Pet Biopharmaceuticals Revenue (US$ Million) & (2019-2024)

7.13.5 CAHIC Recent Developments

8 Industry Chain Analysis

8.1 Pet Biopharmaceuticals Industrial Chain

8.2 Pet Biopharmaceuticals Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Pet Biopharmaceuticals Sales Model

8.5.2 Sales Channel

8.5.3 Pet Biopharmaceuticals Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Dechra Veterinary Products

Chopperlvya Animal Health

CAHIC

List of Tables

Table 1. Pet Biopharmaceuticals Market Trends

Table 2. Pet Biopharmaceuticals Market Drivers & Opportunity

Table 3. Pet Biopharmaceuticals Market Challenges

Table 4. Pet Biopharmaceuticals Market Restraints

Table 5. Global Pet Biopharmaceuticals Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Pet Biopharmaceuticals Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Pet Biopharmaceuticals Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Pet Biopharmaceuticals Product Type

Table 9. Key Companies Time to Begin Mass Production of Pet Biopharmaceuticals

Table 10. Global Pet Biopharmaceuticals Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Biopharmaceuticals as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Pet Biopharmaceuticals Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Pet Biopharmaceuticals Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Pet Biopharmaceuticals Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Pet Biopharmaceuticals Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Pet Biopharmaceuticals Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Pet Biopharmaceuticals Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Pet Biopharmaceuticals Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Pet Biopharmaceuticals Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Pet Biopharmaceuticals Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Pet Biopharmaceuticals Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Pet Biopharmaceuticals Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Pet Biopharmaceuticals Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Pet Biopharmaceuticals Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Pet Biopharmaceuticals Sales Value by Region (2019-2024) & (%)

Table 27. Global Pet Biopharmaceuticals Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Pet Biopharmaceuticals Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Pet Biopharmaceuticals Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Pet Biopharmaceuticals Sales Value, (2025-2030) & (US$ Million)

Table 31. Zoetis Basic Information List

Table 32. Zoetis Description and Business Overview

Table 33. Zoetis Pet Biopharmaceuticals Products, Services and Solutions

Table 34. Revenue (US$ Million) in Pet Biopharmaceuticals Business of Zoetis (2019-2024)

Table 35. Zoetis Recent Developments

Table 36. Boehringer Ingelheim Basic Information List

Table 37. Boehringer Ingelheim Description and Business Overview

Table 38. Boehringer Ingelheim Pet Biopharmaceuticals Products, Services and Solutions

Table 39. Revenue (US$ Million) in Pet Biopharmaceuticals Business of Boehringer Ingelheim (2019-2024)

Table 40. Boehringer Ingelheim Recent Developments

Table 41. Merck Basic Information List

Table 42. Merck Description and Business Overview

Table 43. Merck Pet Biopharmaceuticals Products, Services and Solutions

Table 44. Revenue (US$ Million) in Pet Biopharmaceuticals Business of Merck (2019-2024)

Table 45. Merck Recent Developments

Table 46. Elanco Basic Information List

Table 47. Elanco Description and Business Overview

Table 48. Elanco Pet Biopharmaceuticals Products, Services and Solutions

Table 49. Revenue (US$ Million) in Pet Biopharmaceuticals Business of Elanco (2019-2024)

Table 50. Elanco Recent Developments

Table 51. Virbac Basic Information List

Table 52. Virbac Description and Business Overview

Table 53. Virbac Pet Biopharmaceuticals Products, Services and Solutions

Table 54. Revenue (US$ Million) in Pet Biopharmaceuticals Business of Virbac (2019-2024)

Table 55. Virbac Recent Developments

Table 56. Dechra Veterinary Products Basic Information List

Table 57. Dechra Veterinary Products Description and Business Overview

Table 58. Dechra Veterinary Products Pet Biopharmaceuticals Products, Services and Solutions

Table 59. Revenue (US$ Million) in Pet Biopharmaceuticals Business of Dechra Veterinary Products (2019-2024)

Table 60. Dechra Veterinary Products Recent Developments

Table 61. Ceva Basic Information List

Table 62. Ceva Description and Business Overview

Table 63. Ceva Pet Biopharmaceuticals Products, Services and Solutions

Table 64. Revenue (US$ Million) in Pet Biopharmaceuticals Business of Ceva (2019-2024)

Table 65. Ceva Recent Developments

Table 66. Vetoquinol Basic Information List

Table 67. Vetoquinol Description and Business Overview

Table 68. Vetoquinol Pet Biopharmaceuticals Products, Services and Solutions

Table 69. Revenue (US$ Million) in Pet Biopharmaceuticals Business of Vetoquinol (2019-2024)

Table 70. Vetoquinol Recent Developments

Table 71. Ouro Fino Saude Basic Information List

Table 72. Ouro Fino Saude Description and Business Overview

Table 73. Ouro Fino Saude Pet Biopharmaceuticals Products, Services and Solutions

Table 74. Revenue (US$ Million) in Pet Biopharmaceuticals Business of Ouro Fino Saude (2019-2024)

Table 75. Ouro Fino Saude Recent Developments

Table 76. Norbrook Basic Information List

Table 77. Norbrook Description and Business Overview

Table 78. Norbrook Pet Biopharmaceuticals Products, Services and Solutions

Table 79. Revenue (US$ Million) in Pet Biopharmaceuticals Business of Norbrook (2019-2024)

Table 80. Norbrook Recent Developments

Table 81. Jindun Basic Information List

Table 82. Jindun Description and Business Overview

Table 83. Jindun Pet Biopharmaceuticals Products, Services and Solutions

Table 84. Revenue (US$ Million) in Pet Biopharmaceuticals Business of Jindun (2019-2024)

Table 85. Jindun Recent Developments

Table 86. Chopperlvya Animal Health Basic Information List

Table 87. Chopperlvya Animal Health Description and Business Overview

Table 88. Chopperlvya Animal Health Pet Biopharmaceuticals Products, Services and Solutions

Table 89. Revenue (US$ Million) in Pet Biopharmaceuticals Business of Chopperlvya Animal Health (2019-2024)

Table 90. Chopperlvya Animal Health Recent Developments

Table 91. CAHIC Basic Information List

Table 92. CAHIC Description and Business Overview

Table 93. CAHIC Pet Biopharmaceuticals Products, Services and Solutions

Table 94. Revenue (US$ Million) in Pet Biopharmaceuticals Business of CAHIC (2019-2024)

Table 95. CAHIC Recent Developments

Table 96. Key Raw Materials Lists

Table 97. Raw Materials Key Suppliers Lists

Table 98. Pet Biopharmaceuticals Downstream Customers

Table 99. Pet Biopharmaceuticals Distributors List

Table 100. Research Programs/Design for This Report

Table 101. Key Data Information from Secondary Sources

Table 102. Key Data Information from Primary Sources

Table 103. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Pet Biopharmaceuticals Product Picture

Figure 2. Global Pet Biopharmaceuticals Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Pet Biopharmaceuticals Sales Value (2019-2030) & (US$ Million)

Figure 4. Pet Biopharmaceuticals Report Years Considered

Figure 5. Global Pet Biopharmaceuticals Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Pet Biopharmaceuticals Revenue in 2023

Figure 7. Pet Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Antiparasitic Picture

Figure 9. Biological Products Picture

Figure 10. Antibacterial Picture

Figure 11. Others Picture

Figure 12. Global Pet Biopharmaceuticals Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 13. Global Pet Biopharmaceuticals Sales Value Market Share by Type, 2023 & 2030

Figure 14. Product Picture of Prevention

Figure 15. Product Picture of Treatment

Figure 16. Global Pet Biopharmaceuticals Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global Pet Biopharmaceuticals Sales Value Market Share by Application, 2023 & 2030

Figure 18. North America Pet Biopharmaceuticals Sales Value (2019-2030) & (US$ Million)

Figure 19. North America Pet Biopharmaceuticals Sales Value by Country (%), 2023 VS 2030

Figure 20. Europe Pet Biopharmaceuticals Sales Value (2019-2030) & (US$ Million)

Figure 21. Europe Pet Biopharmaceuticals Sales Value by Country (%), 2023 VS 2030

Figure 22. Asia Pacific Pet Biopharmaceuticals Sales Value (2019-2030) & (US$ Million)

Figure 23. Asia Pacific Pet Biopharmaceuticals Sales Value by Country (%), 2023 VS 2030

Figure 24. South America Pet Biopharmaceuticals Sales Value (2019-2030) & (US$ Million)

Figure 25. South America Pet Biopharmaceuticals Sales Value by Country (%), 2023 VS 2030

Figure 26. Middle East & Africa Pet Biopharmaceuticals Sales Value (2019-2030) & (US$ Million)

Figure 27. Middle East & Africa Pet Biopharmaceuticals Sales Value by Country (%), 2023 VS 2030

Figure 28. Key Countries/Regions Pet Biopharmaceuticals Sales Value (%), (2019-2030)

Figure 29. United States Pet Biopharmaceuticals Sales Value, (2019-2030) & (US$ Million)

Figure 30. United States Pet Biopharmaceuticals Sales Value by Type (%), 2023 VS 2030

Figure 31. United States Pet Biopharmaceuticals Sales Value by Application (%), 2023 VS 2030

Figure 32. Europe Pet Biopharmaceuticals Sales Value, (2019-2030) & (US$ Million)

Figure 33. Europe Pet Biopharmaceuticals Sales Value by Type (%), 2023 VS 2030

Figure 34. Europe Pet Biopharmaceuticals Sales Value by Application (%), 2023 VS 2030

Figure 35. China Pet Biopharmaceuticals Sales Value, (2019-2030) & (US$ Million)

Figure 36. China Pet Biopharmaceuticals Sales Value by Type (%), 2023 VS 2030

Figure 37. China Pet Biopharmaceuticals Sales Value by Application (%), 2023 VS 2030

Figure 38. Japan Pet Biopharmaceuticals Sales Value, (2019-2030) & (US$ Million)

Figure 39. Japan Pet Biopharmaceuticals Sales Value by Type (%), 2023 VS 2030

Figure 40. Japan Pet Biopharmaceuticals Sales Value by Application (%), 2023 VS 2030

Figure 41. South Korea Pet Biopharmaceuticals Sales Value, (2019-2030) & (US$ Million)

Figure 42. South Korea Pet Biopharmaceuticals Sales Value by Type (%), 2023 VS 2030

Figure 43. South Korea Pet Biopharmaceuticals Sales Value by Application (%), 2023 VS 2030

Figure 44. Southeast Asia Pet Biopharmaceuticals Sales Value, (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Pet Biopharmaceuticals Sales Value by Type (%), 2023 VS 2030

Figure 46. Southeast Asia Pet Biopharmaceuticals Sales Value by Application (%), 2023 VS 2030

Figure 47. India Pet Biopharmaceuticals Sales Value, (2019-2030) & (US$ Million)

Figure 48. India Pet Biopharmaceuticals Sales Value by Type (%), 2023 VS 2030

Figure 49. India Pet Biopharmaceuticals Sales Value by Application (%), 2023 VS 2030

Figure 50. Pet Biopharmaceuticals Industrial Chain

Figure 51. Pet Biopharmaceuticals Manufacturing Cost Structure

Figure 52. Channels of Distribution (Direct Sales, and Distribution)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-6P8206

Sun Nov 24 00:00:00 UTC 2024

Add to Cart

Ether Solvent for Pharmaceutical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-22W13490

Sun Nov 24 00:00:00 UTC 2024

Add to Cart

Clinical Trial Imaging Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-0Z6112

Sun Nov 24 00:00:00 UTC 2024

Add to Cart

Smart Pills and Drugs Delivery System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-5Q14261

Fri Nov 22 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Pet Biopharmaceuticals - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: November 2024

Report Code: QYRE-Auto-13W10453

Pet Biopharmaceuticals - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

FEATURED COMPANIES

Pet Biopharmaceuticals - Market Size

Pet Biopharmaceuticals - Market

Report Scope

Scope of Pet Biopharmaceuticals - Market Report

Chapter Outline

FAQ for this report

What is the Pet Biopharmaceuticals - Market size in 2030?

What is the Pet Biopharmaceuticals - Market share by region?

Who are the main players in the Pet Biopharmaceuticals - Market report?

What are the Application segmentation covered in the Pet Biopharmaceuticals - Market report?

What are the Type segmentation covered in the Pet Biopharmaceuticals - Market report?

FEATURED COMPANIES

RELATED REPORTS